These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 33761782)

  • 21. Innate or adaptive immunity? The example of natural killer cells.
    Vivier E; Raulet DH; Moretta A; Caligiuri MA; Zitvogel L; Lanier LL; Yokoyama WM; Ugolini S
    Science; 2011 Jan; 331(6013):44-9. PubMed ID: 21212348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells and cancer therapy, what we know and where we are going.
    Ghaemdoust F; Keshavarz-Fathi M; Rezaei N
    Immunotherapy; 2019 Oct; 11(14):1231-1251. PubMed ID: 31422725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More.
    Vitale M; Cantoni C; Della Chiesa M; Ferlazzo G; Carlomagno S; Pende D; Falco M; Pessino A; Muccio L; De Maria A; Marcenaro E; Moretta L; Sivori S
    Front Immunol; 2019; 10():1415. PubMed ID: 31316503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing NK Cell Memory for Cancer Immunotherapy.
    Fehniger TA; Cooper MA
    Trends Immunol; 2016 Dec; 37(12):877-888. PubMed ID: 27773685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting natural killer cells in cancer immunotherapy.
    Guillerey C; Huntington ND; Smyth MJ
    Nat Immunol; 2016 Aug; 17(9):1025-36. PubMed ID: 27540992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NK cells: immune cross-talk and therapeutic implications.
    Malhotra A; Shanker A
    Immunotherapy; 2011 Oct; 3(10):1143-66. PubMed ID: 21995569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cells: the journey from puzzles in biology to treatment of cancer.
    Bodduluru LN; Kasala ER; Madhana RM; Sriram CS
    Cancer Lett; 2015 Feb; 357(2):454-67. PubMed ID: 25511743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lectin populations of NK cells against tumors coupled to viral infections (review of literature).].
    Lakhtin VM; Lakhtin MV; Mironov AY; Aleshkin VA; Аfanasiev SS
    Klin Lab Diagn; 2019; 64(5):314-320. PubMed ID: 31185156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral inhibitors of NKG2D ligands for tumor surveillance.
    Chávez-Blanco A; Chacón-Salinas R; Dominguez-Gomez G; Gonzalez-Fierro A; Perez-Cardenas E; Taja-Chayeb L; Trejo-Becerril C; Duenas-Gonzalez A
    Expert Opin Ther Targets; 2016 Nov; 20(11):1375-1387. PubMed ID: 27322108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell effector functions in antiviral defense.
    Piersma SJ; Brizić I
    FEBS J; 2022 Jul; 289(14):3982-3999. PubMed ID: 34125493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
    Sabry M; Zubiak A; Hood SP; Simmonds P; Arellano-Ballestero H; Cournoyer E; Mashar M; Pockley AG; Lowdell MW
    PLoS One; 2019; 14(6):e0218674. PubMed ID: 31242243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Natural Killer Cells in Autoimmune Diseases.
    Kucuksezer UC; Aktas Cetin E; Esen F; Tahrali I; Akdeniz N; Gelmez MY; Deniz G
    Front Immunol; 2021; 12():622306. PubMed ID: 33717125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells.
    Littwitz-Salomon E; Dittmer U; Sutter K
    Retrovirology; 2016 Nov; 13(1):77. PubMed ID: 27821119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Cytokine-Induced Memory-Like Natural Killer Cells.
    Berrien-Elliott MM; Wagner JA; Fehniger TA
    J Innate Immun; 2015; 7(6):563-71. PubMed ID: 25924651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New insights into cytotoxic effector cells].
    Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
    Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Natural Cytotoxicity Receptors in Health and Disease.
    Barrow AD; Martin CJ; Colonna M
    Front Immunol; 2019; 10():909. PubMed ID: 31134055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.
    Yang H; Tang R; Li J; Liu Y; Ye L; Shao D; Jin M; Huang Q; Shi J
    Cell Biochem Biophys; 2015 Dec; 73(3):723-9. PubMed ID: 27259316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral Evasion of Natural Killer Cell Activation.
    Ma Y; Li X; Kuang E
    Viruses; 2016 Apr; 8(4):95. PubMed ID: 27077876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-resident lymphocytes: from adaptive to innate immunity.
    Sun H; Sun C; Xiao W; Sun R
    Cell Mol Immunol; 2019 Mar; 16(3):205-215. PubMed ID: 30635650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cell biology: an update and future directions.
    Campbell KS; Hasegawa J
    J Allergy Clin Immunol; 2013 Sep; 132(3):536-544. PubMed ID: 23906377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.